ARN22089 is a novel trisubstituted pyrimidine that acts as an anticancer agent by inhibiting the interaction of CDC42 GTPases with downstream effectors. This mechanism disrupts critical signaling pathways involved in tumorigenesis. In preclinical studies, ARN22089 has demonstrated the ability to inhibit tumor growth in a BRAF mutant mouse melanoma model, making it a valuable compound for research in cancer therapeutics and signaling pathways.
ARN22089 is a novel trisubstituted pyrimidine that acts as an anticancer agent by inhibiting the interaction of CDC42 GTPases with downstream effectors. This mechanism disrupts critical signaling pathways involved in tumorigenesis. In preclinical studies, ARN22089 has demonstrated the ability to inhibit tumor growth in a BRAF mutant mouse melanoma model, making it a valuable compound for research in cancer therapeutics and signaling pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: